Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-31

FDA Approved: OMEPRAZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark's supplemental application for omeprazole, granting approval for the generic proton pump inhibitor product. This action allows Glenmar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)